Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:antigen |
inactivated SARS-CoV-2 virus
|
| gptkbp:associatedWith |
gptkb:BBIBP-CorV
|
| gptkbp:clinicalTrialPhase |
NCT04612972
|
| gptkbp:countryOfOrigin |
gptkb:China
|
| gptkbp:developedBy |
gptkb:Wuhan_Institute_of_Biological_Products
gptkb:Sinopharm |
| gptkbp:dosingSchedule |
two doses
|
| gptkbp:emergencyServices |
gptkb:China
|
| https://www.w3.org/2000/01/rdf-schema#label |
WIBP-CorV
|
| gptkbp:phase3Trials |
conducted in multiple countries
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:storage |
2-8°C
|
| gptkbp:target |
gptkb:COVID-19
|
| gptkbp:type |
inactivated virus vaccine
|
| gptkbp:WHOStatus |
not listed for emergency use by WHO (as of 2024)
|
| gptkbp:bfsParent |
gptkb:Sinopharm_WIBP_COVID-19_vaccine
|
| gptkbp:bfsLayer |
6
|